Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT04652700
Ignite Creation Date: 2024-05-06 @ 3:31 PM
Last Modification Date: 2024-10-26 @ 1:50 PM
Study NCT ID: NCT04652700
Protocol Section: NCT04652700
Start Identification Module Data
Expand Identification Module Data
Brief Title: Oral Islatravir MK-8591 Once-Monthly as Preexposure Prophylaxis PrEP in Men and Transgender Women Who Are at High Risk for HIV-1 Infection MK-8591-024
Official Title: A Phase 3 Randomized Active-Controlled Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Preexposure Prophylaxis in Cisgender Men and Transgender Women Who Have Sex With Men and Are at High Risk for HIV-1 Infection
Acronym: Impower-024
Organization: Merck Sharp Dohme LLC
Organization Class: INDUSTRY
Organization Study ID: 8591-024
Secondary IDs
Secondary ID Type Domain Link
2020-003309-79 EUDRACT_NUMBER jRCT None
MK-8591-024 OTHER None None
jRCT2031200419 REGISTRY None None
Start Status Module Data
Status Verified Date: 2023-08
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Merck Sharp Dohme LLC
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Merck Sharp Dohme LLC
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload